semaglutide od The Effects of on Health-Related Quality of Life in Adults with Type 2 Diabetes and CKD: FLOW trial Thousands overdosed on Ozempic, Wegovy

But certain groups benefit more than others

Just a 1% absolute decline in sugar consumption would result in around 280k tonnes more sugar being available each year

The Meteoric Rise of GLP-1 Utilization The impact of GLP-1s on Medicare spending is already remarkable

The Sequence-anchored clinical platform required workforce restructuring, technology investment, and a brand reset that the broader Wall Street narrative had not yet fully absorbed by 2026

Preference for Oral Weight Loss Pills Oral Wegovy is the first FDA-approved GLP-1 pill for weight loss and is expected to be available in January 2026

Exenatide was the first GLP-1 receptor agonist approved for clinical use in the United States (Byetta, Amylin Pharmaceuticals) in 2005 and since then has been extensively used for T2D treatment in humans and has also shown efficacy in diabetic cats [75,76,77]